Revenue for the third quarter of 2023 was $16.3 million, representing year-over-year growth of 40% on a reported basis over the corresponding period of 2022; Constant currency year-over-year revenue ...
Sophia Genetics (NASDAQ:SOPH) is set to give its latest quarterly earnings report on Tuesday, 2024-11-05. Here's what investors need to know before the announcement. Analysts estimate that Sophia ...
SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, announced today the closing of its previously announced underwritten public offering with total gross proceeds of $57.5 ...
Amortization of capitalized research and development expenses consists of software development costs amortized using the straight-line method over an estimated life of five years. These expenses do ...
Boston, US, and Rolle, Switzerland, September 5, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an ...
BOSTON and GENEVA, Switzerland, Sept. 21, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, hosted its first-ever Investor Day on ...
View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.
15d
Is SOPHiA GENETICS SA (SOPH) Among the Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On?
On June 4, 2026, SOPHiA GENETICS SA (NASDAQ:SOPH) reported that it signed a Memorandum of Understanding with Memorial Sloan Kettering Cancer Center to form a proposed joint venture aimed at building a ...
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q3 2025 Earnings Call Transcript November 4, 2025 SOPHiA GENETICS S.A. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.13. Operator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results